Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 14,720 shares at $19.69 ($290K) on 2022-10-06, disclosed to the SEC on 2022-10-11.
Open-market sale of $290k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.69 | 7,360 | $145K | 50.0% |
| 2 | $19.69 | 7,360 | $145K | 50.0% |
| Total | $19.69 avg | 14,720 | $290K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |